Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Celsis International | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Celsis International

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Philip Vorwald has been appointed vice president and general manager of Celsis International’s In Vitro Technologies (Celsis IVT) division. He will be responsible for setting and overseeing the long-term growth strategy of the company’s ADME-Tox products, which include fresh and cryopreserved cells, enzymes and other media produced for drug development. He will report to Jay LeCoque, Celsis International’s chief executive officer.

“Philip’s extensive life science, international management and business development experience will prove integral in the growth of Celsis IVT,” said Mr. LeCoque. “I’m confident that with Phil’s leadership, Celsis IVT will significantly expand its presence in the ADME-Tox drug development market.”

Mr. Vorwald has 25 years of experience in the global life science industry. Prior to joining the company, he served as senior vice president of commercial operations for Cytonome, Inc., a medical device company, where he was responsible for creating a global customer support division, sales policies and procedures and overseas market entry strategies. Prior to Cytonome, he served in numerous domestic and overseas management positions at Becton Dickinson’s Biosciences division, overseeing the company’s European, Asia-Pacific and Latin American markets. He has also worked for Guava Technologies and Delphi Corp. in business development capacities.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics